Skip to main navigation Skip to main content

CMH : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Articles

Editorial

ASB3 Degrades the Gateway to β-Oxidation: Editorial on “Hepatocytic ASB3 deficiency alleviates MASLD by decreasing ubiquitin-mediated CPT1A”

Ho Jae Ryu1, Ji Su Han1, Ja Hyun Koo1,2orcid
Published online: September 23, 2025
1College of Pharmacy, Seoul National University, Seoul, Korea
2Research Institute of Pharmaceutical Sciences and Natural Products Research Institute, Seoul National University, Seoul, Korea
Corresponding author:  Ja Hyun Koo, Tel: +82-2-880-8586, 
Email: jhkoo@snu.ac.kr
Received: 9 September 2025   • Accepted: 17 September 2025
  • 945 Views
  • 77 Download
  • 1 Crossref
  • 0 Scopus

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

Include:

ASB3 Degrades the Gateway to β-Oxidation: Editorial on “Hepatocytic ASB3 deficiency alleviates MASLD by decreasing ubiquitin-mediated CPT1A”
Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:
Include:
ASB3 Degrades the Gateway to β-Oxidation: Editorial on “Hepatocytic ASB3 deficiency alleviates MASLD by decreasing ubiquitin-mediated CPT1A”
Close